Wei-Fan Chiang

Title: **Innovative Cancer Diagnostic Method by Wei-Fan Chiang**

Introduction

Wei-Fan Chiang, an inventor based in Tainan, Taiwan, has made a significant contribution to the field of cancer diagnosis and prognosis. With a focus on innovative methods of detection, he is dedicated to improving patient outcomes through early diagnosis.

Latest Patents

Chiang holds a patent for a groundbreaking method for cancer diagnosis and prognosis. This patented method enables the determination of whether a subject has or is at risk of developing cancer. The process involves obtaining a sample from the subject, analyzing the levels of at least two target polypeptides selected from ANXA2, HSPA5, KNG1, and MMP1, and assessing the risk of cancer based on these levels. The method serves as a potential means to diagnose and predict the occurrence of oral squamous cell carcinoma, thereby allowing timely therapeutic intervention.

Career Highlights

Wei-Fan Chiang is currently employed by S&T Biomed Co., Ltd., where he utilizes his expertise and innovative thinking to advance the company's research in biomedicine. His work is characterized by a strong commitment to developing effective diagnostic tools that can significantly enhance patient care.

Collaborations

Chiang collaborates with talented coworkers such as Jau-Song Yu and Yi-Ting Chen. Together, they strive to push the boundaries of medical research and develop innovative solutions that address critical healthcare challenges.

Conclusion

Through his innovative work in cancer diagnostics, Wei-Fan Chiang exemplifies the critical role of inventors in advancing medical science. His patented method holds the promise of improving diagnostic accuracy for cancer, ultimately contributing to better healthcare outcomes.